1. Home
  2. SLS vs YXT Comparison

SLS vs YXT Comparison

Compare SLS & YXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • YXT
  • Stock Information
  • Founded
  • SLS 2012
  • YXT 2011
  • Country
  • SLS United States
  • YXT China
  • Employees
  • SLS N/A
  • YXT N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • YXT
  • Sector
  • SLS Health Care
  • YXT
  • Exchange
  • SLS Nasdaq
  • YXT NYSE
  • Market Cap
  • SLS 89.6M
  • YXT 102.1M
  • IPO Year
  • SLS N/A
  • YXT 2024
  • Fundamental
  • Price
  • SLS $1.09
  • YXT $0.99
  • Analyst Decision
  • SLS
  • YXT
  • Analyst Count
  • SLS 0
  • YXT 0
  • Target Price
  • SLS N/A
  • YXT N/A
  • AVG Volume (30 Days)
  • SLS 815.8K
  • YXT 77.3K
  • Earning Date
  • SLS 03-20-2025
  • YXT 03-27-2025
  • Dividend Yield
  • SLS N/A
  • YXT N/A
  • EPS Growth
  • SLS N/A
  • YXT N/A
  • EPS
  • SLS N/A
  • YXT N/A
  • Revenue
  • SLS N/A
  • YXT $45,374,087.00
  • Revenue This Year
  • SLS N/A
  • YXT N/A
  • Revenue Next Year
  • SLS N/A
  • YXT N/A
  • P/E Ratio
  • SLS N/A
  • YXT N/A
  • Revenue Growth
  • SLS N/A
  • YXT N/A
  • 52 Week Low
  • SLS $0.77
  • YXT $0.83
  • 52 Week High
  • SLS $1.84
  • YXT $11.00
  • Technical
  • Relative Strength Index (RSI)
  • SLS 40.56
  • YXT N/A
  • Support Level
  • SLS $1.13
  • YXT N/A
  • Resistance Level
  • SLS $1.25
  • YXT N/A
  • Average True Range (ATR)
  • SLS 0.07
  • YXT 0.00
  • MACD
  • SLS -0.01
  • YXT 0.00
  • Stochastic Oscillator
  • SLS 17.39
  • YXT 0.00

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS

Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.

Share on Social Networks: